ReviewCardiology and therapy2020

What Lessons Have We Learned and What Remains to be Clarified for PCSK9 Inhibitors? A Review of FOURIER and ODYSSEY Outcomes Trials.

Remo H M Furtado et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.